Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.22.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flow from Operating Activities:    
Net (loss) income available to common stockholders $ (8,407) $ 11,926
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Shares and warrants issued to third parties for services 0 46
Depreciation and amortization 839 824
Amortization of debt issuance costs and discounts 26 1,777
Share-based compensation 1,892 2,857
Change in fair value of warrant liabilities 0 (22,873)
Payable-in-kind interest expense on notes payable 0 1,110
Other 255 (930)
Changes in operating assets and liabilities:    
Accounts receivable, net (1,905) (558)
Inventories, net (5,489) (332)
Prepaid expenses and other assets 6 1,256
Accounts payable and accrued liabilities (227) 328
Other 12 (93)
Cash Used in Operating Activities (12,998) (4,662)
Cash Flow from Investing Activities:    
Acquisition of property and equipment (189) (54)
Cash Used in Investing Activities (189) (54)
Cash Flow from Financing Activities:    
Proceeds from shares and warrants issued pursuant to private placement, net 0 4,012
Proceeds from revolving lines of credit 5,000 5,155
Payments on revolving lines of credit (2,500) (5,214)
Proceeds from term loan 0 6,000
Payments on term loans (425) (8,229)
Cash received for warrant exercises 0 1,685
IPO proceeds, net 0 (19)
Debt issuance costs (7) (116)
Cash Provided by Financing Activities 2,068 3,274
Net decrease in cash and cash equivalents and restricted cash (11,119) (1,442)
Total cash and cash equivalents and restricted cash, beginning of period 28,942 3,989
Total cash and cash equivalents and restricted cash, end of period 17,823 2,547
Cash paid during the period for:    
Interest $ 156 $ 221